Fast Screening and Primary Diagnosis of COVID-19 by ATR–FT-IR

Liyang Zhang,Meng Xiao,Yao Wang,Siqi Peng,Yu Chen,Dong Zhang,Dongheyu Zhang,Yuntao Guo,Xinxin Wang,Haiyun Luo,Qun Zhou,Yingchun Xu
DOI: https://doi.org/10.1021/acs.analchem.0c04049
IF: 7.4
2021-01-11
Analytical Chemistry
Abstract:The outbreak of coronavirus disease 2019 (COVID-19) has led to substantial infections and mortality around the world. Fast screening and diagnosis are thus crucial for quick isolation and clinical intervention. In this work, we showed that attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FT-IR) can be a primary diagnostic tool for COVID-19 as a supplement to in-use techniques. It requires only a small volume (∼3 μL) of the serum sample and a shorter detection time (several minutes). The distinct spectral differences and the separability between normal control and COVID-19 were investigated using multivariate and statistical analysis. Results showed that ATR-FT-IR coupled with partial least squares discriminant analysis was effective to differentiate COVID-19 from normal controls and some common respiratory viral infections or inflammation, with the area under the receiver operating characteristic curve (AUROC) of 0.9561 (95% CI: 0.9071-0.9774). Several serum constituents including, but not just, antibodies and serum phospholipids could be reflected on the infrared spectra, serving as "chemical fingerprints" and accounting for good model performances.
chemistry, analytical
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a method for rapid screening and preliminary diagnosis of COVID - 19 to supplement the existing detection techniques. Specifically, the research team hopes to achieve rapid, efficient and accurate detection of COVID - 19 by using attenuated total reflection - Fourier transform infrared spectroscopy (ATR−FT - IR) technology. ### Main problems 1. **Rapid screening and preliminary diagnosis**: Current detection methods such as RT - PCR are standard but time - consuming, and may have a relatively high false - negative rate in some cases. Therefore, a faster and more reliable method is needed for preliminary screening. 2. **Distinguishing COVID - 19 from other respiratory infections or inflammations**: In addition to distinguishing between healthy people and COVID - 19 patients, it is also necessary to be able to distinguish COVID - 19 from other common respiratory virus infections (such as influenza A/B, respiratory syncytial virus RSV) and inflammation - related diseases. ### Solutions The research team solves the above problems through the following steps: 1. **Sample preparation and measurement**: Use a small - volume (about 3 μL) serum sample and complete the detection within a few minutes. 2. **Multivariate and statistical analysis**: Use methods such as principal component analysis (PCA), hierarchical cluster analysis (HCA) and partial least squares discriminant analysis (PLS - DA) to analyze infrared spectral data and identify the characteristic spectral bands of COVID - 19 patients. 3. **Model verification**: Evaluate the performance of the model by the area under the receiver operating characteristic curve (ROC) (AUROC) to ensure its high sensitivity and specificity. ### Key results - **Significant spectral differences**: The study found that there are obvious spectral differences between COVID - 19 patients and the healthy control group, especially in the secondary structure changes of proteins and lipids. - **High accuracy**: The PLS - DA model performs excellently in distinguishing between COVID - 19 patients and the healthy control group, with an AUROC value of 0.9561 (95% CI: 0.9071 − 0.9774). - **Distinguishing other diseases**: This method can also effectively distinguish COVID - 19 from other common respiratory virus infections or inflammation - related diseases. ### Conclusion This study shows that ATR−FT - IR combined with multivariate statistical analysis can be used as a rapid and reliable preliminary diagnosis tool for COVID - 19, especially suitable for the needs of large - scale screening and rapid isolation in clinical interventions.